{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:01:31Z","timestamp":1779141691347,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010870","name":"Qingdao Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2022QNLM030003-2"],"award-info":[{"award-number":["2022QNLM030003-2"]}],"id":[{"id":"10.13039\/501100010870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["202541005"],"award-info":[{"award-number":["202541005"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22477115"],"award-info":[{"award-number":["22477115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118162","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:38:11Z","timestamp":1758087491000},"page":"118162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Structural optimization and biological evaluation of ferrocene-appended RSL3 derivatives as potent ferroptosis inducers"],"prefix":"10.1016","volume":"301","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3222-0211","authenticated-orcid":false,"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118162_bib1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ. Cell Death Differ."},{"key":"10.1016\/j.ejmech.2025.118162_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","article-title":"Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.118162_bib3","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118162_bib4","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2020.04.039","article-title":"SnapShot: ferroptosis","volume":"181","author":"Hadian","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118162_bib5","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2025.118162_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118162_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2025.118162_bib8","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ymthe.2021.03.022","article-title":"Emerging mechanisms and targeted therapy of ferroptosis in cancer","volume":"29","author":"Wang","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2025.118162_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109235","article-title":"The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity","volume":"35","author":"Xu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2025.118162_bib10","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1111\/febs.16059","article-title":"Signaling pathways and defense mechanisms of ferroptosis","volume":"289","author":"Liu","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2025.118162_bib11","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118162_bib12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.tcb.2023.04.005","article-title":"Ferroptosis: mechanisms and implications for cancer development and therapy response","volume":"33","author":"dos Santos","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118162_bib13","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2025.118162_bib14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118162_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117516","article-title":"Identification of imidazo[1,2-a]pyridine-3-amine as a novel drug-like scaffold for efficious ferroptosis inhibition in vivo","volume":"290","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib16","article-title":"A druglike ferrostatin-1 analogue as a ferroptosis inhibitor and photoluminescent indicator","volume":"64","author":"Yan","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118162_bib17","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Angeli","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118162_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118162_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2017.10.023","article-title":"Selenium utilization by GPX4 was an evolutionary requirement to prevent hydroperoxide-induced ferroptosis","volume":"112","author":"Ingold","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.118162_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","article-title":"Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis","volume":"172","author":"Ingold","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118162_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800311","article-title":"GPX4 at the crossroads of lipid homeostasis and ferroptosis","volume":"19","author":"Forcina","year":"2019","journal-title":"Proteomics"},{"key":"10.1016\/j.ejmech.2025.118162_bib22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","article-title":"Role of GPX4 in ferroptosis and its pharmacological implication","volume":"133","author":"Seibt","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.118162_bib23","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","article-title":"GPX4 in cell death, autophagy, and disease","volume":"19","author":"Xie","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2025.118162_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/med.21408","article-title":"The epithelial-to-mesenchymal transition-like process in glioblastoma: an updated systematic review and in silico investigation","volume":"37","author":"Iser","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118162_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118162_bib26","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1021\/acs.jmedchem.1c00569","article-title":"Discovery of a potent glutathione peroxidase 4 inhibitor as a selective ferroptosis inducer","volume":"64","author":"Xu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib27","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.chembiol.2022.11.003","article-title":"Small-molecule allosteric inhibitors of GPX4","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118162_bib28","doi-asserted-by":"crossref","first-page":"10036","DOI":"10.1021\/acs.jmedchem.3c00967","article-title":"Discovery of novel potent covalent glutathione peroxidase 4 inhibitors as highly selective ferroptosis inducers for the treatment of triple-negative breast cancer","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3049","article-title":"Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer","volume":"15","author":"Li","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.118162_bib30","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1039\/D2SC06171F","article-title":"A chiral fluorescent Ir(iii) complex that targets the GPX4 and ErbB pathways to induce cellular ferroptosis","volume":"14","author":"Zhao","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2025.118162_bib31","doi-asserted-by":"crossref","first-page":"19420","DOI":"10.1039\/D4SC05448B","article-title":"A potent and selective anti-glutathione peroxidase 4 nanobody as a ferroptosis inducer","volume":"15","author":"Li","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2025.118162_bib32","first-page":"277","article-title":"Design, synthesis, and biological evaluation of RSL3-based GPX4 degraders with hydrophobic tags","author":"Ning","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-025-01528-1","article-title":"GPX4-AUTAC induces ferroptosis in breast cancer by promoting the selective autophagic degradation of GPX4 mediated by TRAF6-p62","author":"Gong","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2025.118162_bib34","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1021\/acs.jmedchem.4c02530","article-title":"Development of a highly selective ferroptosis inducer targeting GPX4 with 2-Ethynylthiazole-4-carboxamide as electrophilic warhead","volume":"68","author":"Gu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117710","article-title":"Discovery of Artesunate (ARS) PROTACs as GPX4 protein degraders for the treatment of bladder cancer","volume":"293","author":"Yang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib36","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1038\/s41467-024-50993-8","article-title":"Skin hepcidin initiates psoriasiform skin inflammation via Fe-driven hyperproliferation and neutrophil recruitment","volume":"15","author":"Abboud","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118162_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41392-024-02071-0","article-title":"Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.118162_bib38","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s41564-025-02001-y","article-title":"Iron at the crossroads of host-microbiome interactions in health and disease","volume":"10","author":"Choi","year":"2025","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118162_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.590226","article-title":"Iron metabolism in ferroptosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2025.118162_bib40","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2025.118162_bib41","doi-asserted-by":"crossref","first-page":"15916","DOI":"10.1021\/acs.jmedchem.3c01359","article-title":"Design, synthesis, electrochemical, and biological evaluation of fluorescent chlorido[N,N\u2032-bis(methoxy\/hydroxy)salicylidene-1,2-bis(4-methoxyphenyl)ethylenediamine]iron(III) complexes as anticancer agents","volume":"66","author":"Bernkop-Schn\u00fcrch","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib42","doi-asserted-by":"crossref","first-page":"11138","DOI":"10.1021\/acs.jmedchem.4c00641","article-title":"1,3,5-Triaza-7-phosphaadamantane and cyclohexyl groups impart to di-iron(I) complex aqueous solubility and stability, and prominent anticancer activity in cellular and animal models","volume":"67","author":"De Franco","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib43","article-title":"Fenton reaction-based nanomedicine in cancer chemodynamic and synergistic therapy","volume":"21","author":"Meng","year":"2020","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.ejmech.2025.118162_bib44","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1021\/acs.jmedchem.4c01875","article-title":"Combinatorial synthesis toward the discovery of highly cytotoxic Fe(III) complexes","volume":"68","author":"Niemeier","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib45","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.1021\/acs.jmedchem.5c00533","article-title":"Photo-activated ferrocene-iridium(III) prodrug induces immunogenic cell death in melanoma stem cells","volume":"68","author":"Lie","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202104420","article-title":"Anticancer aminoferrocene derivatives inducing production of mitochondrial reactive oxygen species","volume":"28","author":"Gizem \u00d6zkan","year":"2022","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.ejmech.2025.118162_bib47","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1021\/acs.jmedchem.3c01709","article-title":"Deciphering the diversified metabolic behavior of hydroxyalkyl ferrocidiphenols as anticancer complexes","volume":"67","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib48","doi-asserted-by":"crossref","first-page":"9650","DOI":"10.1021\/acs.inorgchem.2c01110","article-title":"Electronic coupling in 1,2,3-triazole bridged ferrocenes and its impact on reactive oxygen species generation and deleterious activity in cancer cells","author":"Bieganski","year":"2022","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib49","doi-asserted-by":"crossref","first-page":"16865","DOI":"10.1021\/acs.jmedchem.1c00390","article-title":"Has ferrocene really delivered its role in accentuating the bioactivity of organic scaffolds?","volume":"64","author":"Sharma","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2020.213658","article-title":"Multifaceted chemical behaviour of metallocene (M = Fe, Os) quinone methides. Their contribution to biology","volume":"430","author":"Vessi\u00e8res","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.118162_bib51","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1039\/D4QI03268C","article-title":"Synthesis and bio-evaluation of aminoferrocene-based anticancer prodrugs as potent ferroptosis inducers","author":"Zhang","year":"2025","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.ejmech.2025.118162_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202300813","article-title":"Design, synthesis, and evaluation of biological activity of ferrocene-ispinesib hybrids: impact of a ferrocenyl group on the antiproliferative and kinesin spindle protein inhibitory activity","volume":"29","author":"Kowalczyk","year":"2023","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.ejmech.2025.118162_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112109","article-title":"Ferrocene-containing hybrids as potential anticancer agents: current developments, mechanisms of action and structure-activity relationships","volume":"190","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41570-017-0066","article-title":"The medicinal chemistry of ferrocene and its derivatives","volume":"1","author":"Patra","year":"2017","journal-title":"Nat. Rev. Chem"},{"key":"10.1016\/j.ejmech.2025.118162_bib55","doi-asserted-by":"crossref","first-page":"16353","DOI":"10.1021\/acs.jmedchem.2c01174","article-title":"Potent ruthenium-ferrocene bimetallic antitumor antiangiogenic agent that circumvents platinum resistance: from synthesis and mechanistic studies to in vivo evaluation in zebrafish","volume":"65","author":"Manikandan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115004","article-title":"Synthesis and bioactivity evaluation of ferrocene-based hydroxamic acids as selective histone deacetylase 6 inhibitors","volume":"246","author":"Yan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib57","article-title":"Ferroptosis-enhanced cancer immunity by a ferrocene-appended iridium(III) diphosphine complex","volume":"61","author":"Wang","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118162_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114202","article-title":"Diversity-oriented synthesis and bioactivity evaluation of N-substituted ferrocifen compounds as novel antiproliferative agents against TNBC cancer cells","volume":"234","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib59","doi-asserted-by":"crossref","first-page":"16038","DOI":"10.1039\/D4DT01853B","article-title":"Design and synthesis of ferrocenyl 1,4-dihydropyridines and their evaluation as kinesin-5 inhibitors","volume":"53","author":"Kowalczyk","year":"2024","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2025.118162_bib60","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.1039\/D4SC02002B","article-title":"How does ferrocene correlate with ferroptosis? Multiple approaches to explore ferrocene-appended GPX4 inhibitors as anticancer agents","volume":"15","author":"Li","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2025.118162_bib61","doi-asserted-by":"crossref","first-page":"15828","DOI":"10.1021\/acs.jmedchem.5c00839","article-title":"Diversity-Oriented synthesis toward the discovery of ferrocenophane-appended GPX4 inhibitors as potent ferroptosis inducers with drug likeness","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118162_bib62","doi-asserted-by":"crossref","first-page":"11943","DOI":"10.1002\/anie.201805955","article-title":"ROS-responsive N-alkylaminoferrocenes for cancer-cell-specific targeting of mitochondria","volume":"57","author":"Reshetnikov","year":"2018","journal-title":"Angew. Chem. Int. Ed."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:28:30Z","timestamp":1773127710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":62,"alternative-id":["S0223523425009274"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118162","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural optimization and biological evaluation of ferrocene-appended RSL3 derivatives as potent ferroptosis inducers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118162"}}